Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve sustainable funding for community pharmacies to (a) support people with lung conditions and (b) reduce hospital admissions.

We have concluded the most recent consultation on funding for 2024/25 and 2025/26 with the community pharmacy sector. This deal represents a funding increase of over 19% across 2024/25 and 2025/26 and will support community pharmacies in continuing to provide clinical services.

This includes the New Medicine Service, which focuses on treatments for long-term conditions, including asthma and chronic obstructive pulmonary disease. Pharmacists provide advice on side effects and address issues or questions that patients who are prescribed a new medicine may have. In addition, patients moved from secondary to primary care continue to be supported by the Discharge Medicines Service providing advice on medication changes. Interventions of this type seek to improve medication adherence and patient outcomes as well as to reduce pressure on the wider National Health Service. Community pharmacies are further funded to support patients with asthma through the Pharmacy Quality Scheme, providing additional support to patients aged between five and 15 years old using a spacer and patients using short-acting bronchodilators.